×
About 125 results

ALLMedicine™ Lambert-eaton Myasthenic Syndrome Center

Research & Reviews  40 results

Lambert-Eaton Myasthenic Syndrome in Lung Cancer.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277170
Contrast Media & Molecular Imaging; Wang Y, Xu C et. al.

Jul 21st, 2022 - The aim is to study lung cancer with Lambert-Eaton myasthenic syndrome (LEMS) with clinical and electrical characteristics of physiology and prognosis. Fourteen LEMS patients with lung cancer were studied retrospectively. The data including demogr...

Plasma lncRNA LOC338963 and mRNA AP3B2 are upregulated in paraneoplastic Lambert-Eaton ...
https://doi.org/10.1002/mus.27571
Muscle & Nerve; Yang F, Jing F et. al.

May 5th, 2022 - Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune neuromuscular junction disorder. Long noncoding RNA (lncRNA) can regulate the expression of mRNA and is involved in the development of autoimmune diseases, but few genetic studies are avail...

Autonomic dysfunction detected by skin sympathetic response in Lambert-Eaton myasthenic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933941
BMC Neurology; Zhang J, Huang X et. al.

Mar 21st, 2022 - Lambert-Eaton myasthenic syndrome (LEMS) is a type of paraneoplastic syndrome that may initially manifest itself with proximal weakness and gait abnormalities. Approximately up to 50% of LEMS patients have a primary autonomic dysfunction. We prese...

Lambert-Eaton myasthenic syndrome in a young girl.
https://doi.org/10.1136/bcr-2021-245773
BMJ Case Reports; Moor SE, Gardin T

Mar 2nd, 2022 - Lambert-Eaton Myasthenic Syndrome (LEMS) is a neuromuscular junction defect that results in weakness. It is rarely seen in children and most commonly is associated with small-cell lung cancer. Diagnosis of LEMS requires characteristic electromyogr...

Myasthenia gravis associated with a pelvic follicular lymphoma.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8762130
BMJ Case Reports; Willis C, Williamson M et. al.

Jan 15th, 2022 - An 81-year-old woman presented with neck weakness, dysarthria, dysphasia and left-sided ptosis. Myasthenia gravis (MG) was strongly suspected. Voltage gated calcium channel (VGCC) antibodies, associated with Lambert-Eaton myasthenic syndrome (LEMS...

see more →

Guidelines  1 results

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic synd...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105910
Journal of the Neurological Sciences; , Jacob S et. al.

Apr 5th, 2020 - Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.|2020| ,Jacob S,Muppidi S,Guidon A,Guptill J,|complications,drug therapy,epidemiology,therapeutic use,therapeutic use,t...

see more →

Drugs  2 results see all →

News  7 results

Ruzurgi approved for Lambert-Eaton myasthenic syndrome in patients under age 17
https://www.mdedge.com/clinicalneurologynews/article/200494/neuromuscular-disorders/ruzurgi-approved-lambert-eaton?channel=285
Mary Jo M. Dales, Clinical Neurology News

May 8th, 2019 - Amifampridine (Ruzurgi) has been approved for the treatment of Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune neuromuscular disorder, in patients aged 6 to less than 17 years, according to a statement from the Food and Drug Administra.

FDA OKs First Treatment for Kids With Lambert-Eaton Myasthenic Syndrome
https://www.medscape.com/viewarticle/912722

May 8th, 2019 - The US Food and Drug Administration (FDA) has approved the first treatment for children with Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder. Amifampridine (Ruzurgi, Jacobus Pharmacuetical) is an oral potassium channel blocker...

FDA OKs First Treatment for Kids With Lambert-Eaton Myasthenic Syndrome
https://www.staging.medscape.com/viewarticle/912722

May 8th, 2019 - The US Food and Drug Administration (FDA) has approved the first treatment for children with Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder. Amifampridine (Ruzurgi, Jacobus Pharmacuetical) is an oral potassium channel blocker...

A 56-Year-Old Woman With Paresthesia and Choking
https://reference.medscape.com/viewarticle/906864_3

Dec 26th, 2018 - Discussion Lambert-Eaton myasthenic syndrome (LEMS) is a rare disorder of the neuromuscular junction, which is the synapse between the motor nerve endings and their associated muscle receptors.[1] Antibodies against the voltage-gated calcium chann...

FDA OKs First Treatment for Lambert-Eaton Myasthenic Syndrome
https://www.staging.medscape.com/viewarticle/905808

Nov 30th, 2018 - The US Food and Drug Administration (FDA) has approved amifampridine (Firdapse, Catalyst Pharmaceuticals) 10-mg tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults. Amifampridine, a potassium channel blocker, is the fir...

see more →